Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 1361 entries
View as:

Ischaemic Pre-Conditioning in Elective Percutaneous Coronary Intervention (PCI) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00765908 Org: User:
Start: 10/31/08 End: 10/31/09 Due: 10/31/10

Ovarian Tumor Biopsies to Study Response to Treatments

Phase: N/A Priority: Normal
NCT ID: NCT02952521 Org: User:
Start: 01/25/17 End: 10/28/21 Due: 10/28/22

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02869217 Org: User:
Start: 09/30/16 End: 09/30/25 Due: 09/30/26

Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques

Phase: N/A Priority: Normal
NCT ID: NCT00242034 Org: User:
Start: - End: - Due: -

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04084717 Org: User:
Start: 12/03/19 End: 06/30/25 Due: 06/30/26

ALTERNATE DAY ULTRAHYPOFRACTIONATED OR DAILY MODERATELY HYPOFRACTIONATED POST OPERATIVE RADIOTHERAPY (AMPORA)

Phase: N/A Priority: Normal
NCT ID: NCT06409910 Org: User:
Start: 11/25/24 End: 11/30/30 Due: 11/30/31

Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

Phase: N/A Priority: Normal
NCT ID: NCT01227798 Org: User:
Start: 11/30/10 End: 11/30/11 Due: 11/30/12

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Phase: N/A Priority: Normal
NCT ID: NCT06442930 Org: User:
Start: 04/14/25 End: 12/31/26 Due: 12/31/27

Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study

Phase: N/A Priority: Normal
NCT ID: NCT03380208 Org: User:
Start: 12/01/17 End: 09/30/23 Due: 09/30/24

Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06887270 Org: User:
Start: 09/30/25 End: 09/30/27 Due: 09/30/28

Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT06877598 Org: User:
Start: 03/31/25 End: 12/31/27 Due: 12/31/28

Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study

Phase: N/A Priority: Normal
NCT ID: NCT03575598 Org: User:
Start: 08/30/18 End: 02/18/20 Due: 02/18/21

Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial)

Phase: N/A Priority: Normal
NCT ID: NCT05473689 Org: User:
Start: 08/15/22 End: 07/31/25 Due: 07/31/26

A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib

Phase: N/A Priority: Normal
NCT ID: NCT02340611 Org: User:
Start: 06/30/15 End: 06/30/18 Due: 06/30/19

Treatment-free Remission Accomplished With Dasatinib in Patients With CML

Phase: N/A Priority: Normal
NCT ID: NCT02268370 Org: User:
Start: 10/31/14 End: 10/31/21 Due: 10/31/22

Patient Reported Outcomes/Metrics Program Trial

Phase: N/A Priority: Normal
NCT ID: NCT04983199 Org: User:
Start: 11/24/22 End: 09/30/27 Due: 09/30/28

IL-1 Inhibition in Early TNBC

Phase: N/A Priority: Normal
NCT ID: NCT06710197 Org: User:
Start: 03/05/25 End: 11/30/27 Due: 11/30/28

Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04044040 Org: User:
Start: 09/30/16 End: 07/31/18 Due: 07/31/19

A Novel Combined Neuromodulation Therapy to Enhance Balance and Neuroplasticity

Phase: N/A Priority: Normal
NCT ID: NCT05940636 Org: User:
Start: 09/30/23 End: 07/31/25 Due: 07/31/26

Dexamethasone in Total Knee and Total Hip Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT02760043 Org: User:
Start: 04/30/16 End: 10/31/18 Due: 10/31/19

The Translational Research Image-Guided Operating Room (TRIGORA): Intraoperative 3D Imaging for Head & Neck Surgical Patients

Phase: N/A Priority: Normal
NCT ID: NCT03345719 Org: User:
Start: 10/04/12 End: 03/31/19 Due: 03/31/20

Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)

Phase: N/A Priority: Normal
NCT ID: NCT00500383 Org: User:
Start: 10/31/09 End: 07/31/15 Due: 07/31/16

Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events

Phase: N/A Priority: Normal
NCT ID: NCT00923416 Org: User:
Start: 09/30/08 End: 11/30/10 Due: 11/30/11

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04665388 Org: User:
Start: 11/30/20 End: 02/28/26 Due: 02/28/27

Identifying Prostate Brachytherapy Seeds Using MRI

Phase: N/A Priority: Normal
NCT ID: NCT01878058 Org: User:
Start: 10/31/12 End: 08/31/16 Due: 08/31/17